{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:02:52Z","timestamp":1787068972149,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11655-026-4034-y","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:18:03Z","timestamp":1773659883000},"page":"536-544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Berberine Ameliorates Angiotensin II-Induced Endothelial Dysfunction by Blocking AT1R, Inhibiting PDE4b and Activating AKT\/eNOS Pathway"],"prefix":"10.1007","volume":"32","author":[{"given":"Ting-yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-ning","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-you","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-hong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"4034_CR1","unstructured":"WHO. Raised blood pressure\u2013situation and trends. Available at https:\/\/www.who.int\/data\/gho\/indicator-metadata-registry\/imr-details\/3155: Global Health Observatory (GHO) Data; 2017."},{"key":"4034_CR2","first-page":"949","volume":"37","author":"Center for Cardiovascular Diseases the Writing Committee of the Report on Cardiovascular Health and Diseases in China","year":"2024","unstructured":"Center for Cardiovascular Diseases the Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2023: an updated summary. Biomed Environ Sci 2024;37:949\u2013992.","journal-title":"Biomed Environ Sci"},{"key":"4034_CR3","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.123.323596","volume":"134","author":"A Dikalova","year":"2024","unstructured":"Dikalova A, Fehrenbach D, Mayorov V, Panov A, Ao M, Lantier L, et al. Mitochondrial CypD acetylation promotes endothelial dysfunction and hypertension. Circ Res 2024;134:1451\u20131464.","journal-title":"Circ Res"},{"key":"4034_CR4","doi-asserted-by":"publisher","first-page":"101287","DOI":"10.1016\/j.ctcp.2020.101287","volume":"42","author":"MT Suadoni","year":"2021","unstructured":"Suadoni MT, Atherton I. Berberine for the treatment of hypertension: a systematic review. Complement Ther Clin Pract 2021;42:101287.","journal-title":"Complement Ther Clin Pract"},{"key":"4034_CR5","doi-asserted-by":"publisher","first-page":"1455534","DOI":"10.3389\/fphar.2024.1455534","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Bi C, Xi H, Wei F. Effects of administering berberine alone or in combination on type 2 diabetes mellitus: a systematic review and meta-analysis. Front Pharmacol 2024;15:1455534.","journal-title":"Front Pharmacol"},{"key":"4034_CR6","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1142\/S0192415X21500762","volume":"49","author":"RY Cao","year":"2021","unstructured":"Cao RY, Zheng Y, Zhang Y, Jiang L, Li Q, Sun W, et al. Berberine on the prevention and management of cardiometabolic disease: clinical applications and mechanisms of action. Am J Chin Med 2021;49:1645\u20131666.","journal-title":"Am J Chin Med"},{"key":"4034_CR7","doi-asserted-by":"publisher","first-page":"e0247621","DOI":"10.1371\/journal.pone.0247621","volume":"16","author":"N Tan","year":"2021","unstructured":"Tan N, Zhang Y, Zhang Y, Li L, Zong Y, Han W, et al. Berberine ameliorates vascular dysfunction by a global modulation of lncRNA and mRNA expression profiles in hypertensive mouse aortae. PLoS One 2021;16:e0247621.","journal-title":"PLoS One"},{"key":"4034_CR8","doi-asserted-by":"publisher","first-page":"114095","DOI":"10.1016\/j.biopha.2022.114095","volume":"158","author":"Z Pan","year":"2023","unstructured":"Pan Z, Wu X, Zhang X, Hu K. Phosphodiesterase 4B activation exacerbates pulmonary hypertension induced by intermittent hypoxia by regulating mitochondrial injury and cAMP\/PKA\/p-CREB\/PGC-1\u03b1 signaling. Biomed Pharmacother 2023;158:114095.","journal-title":"Biomed Pharmacother"},{"key":"4034_CR9","first-page":"52965","volume":"118","author":"JM Wang","year":"2016","unstructured":"Wang JM, Chen AF, Zhang K. Isolation and primary culture of mouse aortic endothelial cells. J Vis Exp 2016;118:52965.","journal-title":"J Vis Exp"},{"key":"4034_CR10","first-page":"469","volume":"2018","author":"P Kumar","year":"2018","unstructured":"Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the MTT assay. Cold Spring Harb Protoc 2018;2018:469\u2013471.","journal-title":"Cold Spring Harb Protoc"},{"key":"4034_CR11","doi-asserted-by":"publisher","first-page":"11384","DOI":"10.3390\/ijms231911384","volume":"23","author":"Q Yao","year":"2022","unstructured":"Yao Q, Zou X, Liu S, Wu H, Shen Q, Kang J. Oxidative stress as a contributor to insulin resistance in the skeletal muscles of mice with polycystic ovary syndrome. Int J Mol Sci 2022;23:11384.","journal-title":"Int J Mol Sci"},{"key":"4034_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41422-020-00464-8","volume":"31","author":"Y Fu","year":"2021","unstructured":"Fu Y, Huang Y, Yang Z, Chen Y, Zheng J, Mao C, et al. Cartilage oligomeric matrix protein is an endogenous \u03b2-arrestin-2-selective allosteric modulator of AT1 receptor counteracting vascular injury. Cell Res 2021;31:773\u2013790.","journal-title":"Cell Res"},{"key":"4034_CR13","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1038\/s41467-021-25020-9","volume":"12","author":"S Lu","year":"2021","unstructured":"Lu S, He X, Yang Z, Chai Z, Zhou S, Wang J, et al. Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design. Nat Commun 2021;12:4721.","journal-title":"Nat Commun"},{"key":"4034_CR14","doi-asserted-by":"publisher","first-page":"8817431","DOI":"10.1155\/2023\/8817431","volume":"2023","author":"X Wu","year":"2023","unstructured":"Wu X, Wang A, Xu L, Li M, Zhai Q, Wang W, et al. Valsartan attenuated homocysteine-induced impaired autophagy and er stress in human umbilical vein endothelial cells. Cardiovasc Ther 2023;2023:8817431.","journal-title":"Cardiovasc Ther"},{"key":"4034_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina D, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 2013;341:84\u201387.","journal-title":"Science"},{"key":"4034_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.7150\/ijms.79741","volume":"20","author":"SC Li","year":"2023","unstructured":"Li SC, Jiang TM, Zhang JH, Zeng MY, Ma YX, Feng SY, et al. Salt restriction and angiotensin-converting enzyme inhibitor improve the responsiveness of the small artery in salt-sensitive hypertension. Int J Med Sci 2023;20:572\u2013580.","journal-title":"Int J Med Sci"},{"key":"4034_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/eurheartj\/ehad842","volume":"45","author":"E Ma","year":"2024","unstructured":"Ma E, Wo D, Chen J, Yan H, Zhou X, He J, et al. Inhibition of a novel Dickkopf-1-LDL receptor-related proteins 5 and 6 axis prevents diabetic cardiomyopathy in mice. Eur Heart J 2024;45:688\u2013703.","journal-title":"Eur Heart J"},{"key":"4034_CR18","doi-asserted-by":"publisher","first-page":"127824","DOI":"10.1016\/j.micres.2024.127824","volume":"287","author":"Z Wang","year":"2024","unstructured":"Wang Z, Shao Y, Wu F, Luo D, He G, Liang J, et al. Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension. Microbiol Res 2024;287:127824.","journal-title":"Microbiol Res"},{"key":"4034_CR19","doi-asserted-by":"publisher","first-page":"20284","DOI":"10.1073\/pnas.2009029117","volume":"117","author":"C McMahon","year":"2020","unstructured":"McMahon C, Staus DP, Wingler LM, Wang J, Skiba MA, Elgeti M, et al. Synthetic nanobodies as angiotensin receptor blockers. Proc Natl Acad Sci U S A 2020;117:20284\u201320291.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4034_CR20","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jamaneurol.2024.1714","volume":"81","author":"X Wen","year":"2024","unstructured":"Wen X, Otoo MN, Tang J, Brothers T, Ward KE, Asal N, et al. Angiotensin receptor blockers for hypertension and risk of epilepsy. JAMA Neurol 2024;81:866\u2013874.","journal-title":"JAMA Neurol"},{"key":"4034_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-023-01266-0","volume":"26","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Orchard SG, Nelson MR, Fravel MA, Ernst ME. Angiotensin receptor blockers and cognition: a scoping review. Curr Hypertens Rep 2024;26:1\u201319.","journal-title":"Curr Hypertens Rep"},{"key":"4034_CR22","doi-asserted-by":"publisher","first-page":"e2019126118","DOI":"10.1073\/pnas.2019126118","volume":"118","author":"KD Singh","year":"2021","unstructured":"Singh KD, Jara ZP, Harford T, Saha PP, Pardhi TR, Desnoyer R, et al. Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers. Proc Natl Acad Sci U S A 2021;118:e2019126118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4034_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0167-0115(95)00085-P","volume":"59","author":"M de Gasparo","year":"1995","unstructured":"de Gasparo M, Whitebread S. Binding of valsartan to mammalian angiotensin AT1 receptors. Regul Pept 1995;59:303\u2013311.","journal-title":"Regul Pept"},{"key":"4034_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0895-7061(99)00250-2","volume":"13","author":"S Oparil","year":"2000","unstructured":"Oparil S. Newly emerging pharmacologic differences in angiotensin II receptor blockers. Am J Hypertens 2000;13:18\u201324.","journal-title":"Am J Hypertens"},{"key":"4034_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s40256-016-0165-4","volume":"16","author":"CA D\u00e9zsi","year":"2016","unstructured":"D\u00e9zsi CA. The different therapeutic choices with ARBs. which one to give? when? why? Am J Cardiovasc Drugs 2016;16:255\u2013266.","journal-title":"Am J Cardiovasc Drugs"},{"key":"4034_CR26","doi-asserted-by":"publisher","first-page":"1013055","DOI":"10.3389\/fnut.2022.1013055","volume":"9","author":"M Zamani","year":"2022","unstructured":"Zamani M, Zarei M, Nikbaf-Shandiz M, Hosseini S, Shiraseb F, Asbaghi O. The effects of berberine supplementation on cardiovascular risk factors in adults: a systematic review and dose-response meta-analysis. Front Nutr 2022;9:1013055.","journal-title":"Front Nutr"},{"key":"4034_CR27","doi-asserted-by":"publisher","first-page":"155258","DOI":"10.1016\/j.phymed.2023.155258","volume":"128","author":"K Wang","year":"2024","unstructured":"Wang K, Yin J, Chen J, Ma J, Si H, Xia D. Inhibition of inflammation by berberine: molecular mechanism and network pharmacology analysis. Phytomedicine 2024;128:155258.","journal-title":"Phytomedicine"},{"key":"4034_CR28","doi-asserted-by":"publisher","first-page":"102637","DOI":"10.1016\/j.tice.2024.102637","volume":"91","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li S, Hou X, Jia Y. PDE4B abrogation extenuates angiotensin II-induced endothelial dysfunction related to hypertension through up-regulation of AMPK\/Sirt1\/Nrf2\/ARE signaling. Tissue Cell 2024;91:102637.","journal-title":"Tissue Cell"},{"key":"4034_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0960-894X(98)00058-4","volume":"8","author":"V Segarra","year":"1998","unstructured":"Segarra V, Crespo MI, Pujol F, Beleta J, Dom\u00e9nech T, Miralpeix M, et al. Phosphodiesterase inhibitory properties of losartan. Design and synthesis of new lead compounds. Bioorg Med Chem Lett 1998;8:505\u2013510.","journal-title":"Bioorg Med Chem Lett"},{"key":"4034_CR30","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.18632\/aging.205589","volume":"16","author":"S Hao","year":"2024","unstructured":"Hao S, He Q, Yuan Y, Mu Q. The protective effects of Irbesartan in cognitive impairment in hypertension. Aging (Albany NY) 2024;16:5065\u20135076.","journal-title":"Aging (Albany NY)"},{"key":"4034_CR31","doi-asserted-by":"publisher","first-page":"982130","DOI":"10.3389\/fphar.2022.982130","volume":"13","author":"Y Su","year":"2022","unstructured":"Su Y, Ding J, Yang F, He C, Xu Y, Zhu X, et al. The regulatory role of PDE4B in the progression of inflammatory function study. Front Pharmacol 2022;13:982130.","journal-title":"Front Pharmacol"},{"key":"4034_CR32","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.7150\/ijbs.99936","volume":"20","author":"W Zhang","year":"2024","unstructured":"Zhang W, Gao L, Zhang X, Weng Y, Du Y, Sun YL, et al. Theophylline derivatives promote primordial follicle activation via cAMP-PI3K\/Akt pathway and ameliorate fertility deficits in naturally aged mice. Int J Biol Sci 2024;20:5312\u20135329.","journal-title":"Int J Biol Sci"},{"key":"4034_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/13813455.2022.2102655","volume":"130","author":"X Liu","year":"2024","unstructured":"Liu X, Li MH, Zhao YY, Xie YL, Yu X, Chen YJ, et al. LncRNA H19 deficiency protects against the structural damage of glomerular endothelium in diabetic nephropathy via Akt\/eNOS pathway. Arch Physiol Biochem 2024;130:401\u2013410.","journal-title":"Arch Physiol Biochem"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4034-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-026-4034-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4034-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:40:14Z","timestamp":1780454414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-026-4034-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4034"],"URL":"https:\/\/doi.org\/10.1007\/s11655-026-4034-y","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"21 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}